Evaluation of the Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Neoplasm Female
- Sponsor
- Fudan University
- Enrollment
- 82
- Locations
- 1
- Primary Endpoint
- Material domain of financial toxicity
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The goal of this study is to access the impact of a financial navigation program on improving financial toxicity among patients with breast cancer in China.
The main questions it aims to answer are:
- Does the intervention alleviate participants' financial toxicity?
- Does the intervention enhance participants' cost-related health literacy?
- Does the intervention improve participants' shared decision-making?
- Does the intervention reduce participants' perceived stress?
Researchers will compare the financial navigation program with usual oncology care to evaluate its effectiveness.
Participants will receive the comprehensive financial navigation, including:
- Needs assessment;
- Cost-related health education, mainly including topics regarding communication of cost, treatment-related cost, health insurance policies, and family support;
- Resource and service referral;
- Personalized counseling.
Investigators
Xiaoyi Yuan
Principal Investigator
Fudan University
Eligibility Criteria
Inclusion Criteria
- •Newly diagnosed with breast cancer and undergoing surgery during this admission;
- •Female, age 18 years or older;
- •Receiving or expected to receive one or more of the following therapies: chemotherapy, radiotherapy, endocrine therapy, targeted therapy, and immunotherapy;
- •Eastern Cooperative Oncology Group Performance Status 0-2;
- •Provided informed consent to participate in this study.
Exclusion Criteria
- •Diagnosed with ductal carcinoma in situ (DCIS)
- •Presence of any serious psychiatric disorders;
- •Cognitive impairments;
- •Difficulty in reading, writing, or communicating in Chinese.
Outcomes
Primary Outcomes
Material domain of financial toxicity
Time Frame: 1st month and 3rd month since baseline
Material domain of financial toxicity will be measured with 2 items adapted from the Medical Expenditure Panel Survey (MEPS).
Financial toxicity
Time Frame: Baseline, 1st month and 3rd month since baseline
Financial toxicity will be measured with the Comprehensive Score for Financial Toxicity-Functional Assessment of Chronic Illness Therapy Version 2 (COST-FACIT-V2); lower scores (range, 0-44) indicating greater financial toxicity.
Behavioral domain of financial toxicity
Time Frame: 1st month and 3rd month since baseline
Behavioral domain of financial toxicity will be measured by employment changes and cost-related nonadherence with 6 items adapted from MEPS and previous literature.
Secondary Outcomes
- Perceived stress(Baseline, 1st month and 3rd month since baseline)
- Shared decision-making(Baseline, 1st month and 3rd month since baseline)
- Cost-related health literacy(Baseline, 1st month and 3rd month since baseline)